• Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    14 hours ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022

  • Pauwels Consulting takes over Science@Work

    Friday September 23rd 2022

  • FIT verhoogt budget voor Starterspakket Internationalisering tot 1,4 miljoen euro

    Thursday September 22nd 2022

  • IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225

    Thursday September 22nd 2022

  • Researchers identify which cancer cell subpopulations cause tumor growth and metastasis

    Thursday September 22nd 2022

  • Mithra and Lotus announce approval of ALYSSA®, an innovative oral contraceptive, in both Taiwan and Hong Kong

    Wednesday September 21st 2022

  • Your news here?

  • argenx submits Biologics License Application to U.S. Food and Drug Administration for subcutaneous efgartigimod for treatment of generalized myasthenia gravis

    Wednesday September 21st 2022

  • Cellistic and Celyad Oncology announce GMP cell therapy manufacturing operations transaction

    Tuesday September 20th 2022

  • European Medicine Agency accepts marketing authorization applications for bimekizumab in psoriatic arthritis and axial spondyloarthritis

    Tuesday September 20th 2022


Strategic Partners